In transfusion-dependent, angiodysplasia-related anemia, adding octreotide to usual care reduced transfusions at 1 y.

在依赖输血的情况下 ，血管发育不良相关性贫血 ，在常规护理中添加奥曲肽可减少 1 年时的输血。

• 影响指数: 51.598
• 发表时间: 2024 Jun 4
• 来源期刊: Ann Intern Med
• DOI: 10.7326/ANNALS-24-00517-JC
• PMID: 38830221
• 文章类型: Journal Article
• 中科院分区: Q1
• 方向: 医学
• 作者列表: Flynn DJ,Feuerstein JD

Mesh: Aged; Female; Humans; Male; Middle Aged; Anemia / drug therapy etiology therapy; Angiodysplasia / complications; Blood Transfusion; Gastrointestinal Agents / therapeutic use; Gastrointestinal Hemorrhage / therapy etiology; Multicenter Studies as Topic; Octreotide / therapeutic use; Randomized Controlled Trials as Topic

Abstract

UNASSIGNED: Goltstein LC, Grooteman KV, Bernts LH, et al. Standard of care versus octreotide in angiodysplasia-related bleeding (the OCEAN study): a multicenter randomized controlled trial. Gastroenterology. 2024;166:690-703. 38158089.

摘要

■GoltsteinLC，GrootemanKV,伯茨LH,etal.治疗标准与奥曲肽治疗血管增生相关出血（OCEAN研究）：一项多中心随机对照试验。胃肠病学。2024；166：690-703。38158089.